Skip Navigation



Human Molecular Genetics Advance Access published online on January 11, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddi472
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
15/4/555    most recent
ddi472v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Haacke, A.
Right arrow Articles by Breuer, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haacke, A.
Right arrow Articles by Breuer, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved
Received October 12, 2005
Revised December 6, 2005
Accepted January 4, 2006

Article

Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3

Annette Haacke 1, Sarah A. Broadley 1, Raina Boteva 2, Nikolay Tzvetkov 1, F. Ulrich Hartl 1 *, and Peter Breuer 1 *

1 Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany
2 Radiobiology Department, National Center of Radiobiology and Radiation Protection, 1756 Sofia, Bulgaria

* To whom correspondence should be addressed.
F. Ulrich Hartl, E-mail: uhartl{at}biochem.mpg.de
Peter Breuer, E-mail: breuer{at}biochem.mpg.de


  Abstract

Spinocerebellar ataxia type 3 (SCA3), like other polyglutamine (polyQ) diseases, is characterized by the formation of intraneuronal inclusions, but the mechanism underlying their formation is poorly understood. Here, we tested the ‘toxic fragment hypothesis’, which predicts that proteolytic production of polyQ-containing fragments from the full-length disease protein initiates the aggregation process associated with inclusion formation and cellular dysfunction. We demonstrate that the removal of the N-terminus of polyQ-expanded ataxin-3 (AT3) is required for aggregation in vitro and in vivo. Consistently, proteolytic cleavage of full-length, pathogenic AT3 initiates the formation of sodium dodecylsulfate-resistant aggregates in neuroblastoma cells. Although full-length AT3 does not readily aggregate on its own, it is susceptible to co-aggregation with polyQ-expanded AT3 fragments. Interestingly, interaction with soluble polyQ-elongated fragments causes a structural distortion of wild-type AT3 prior to the formation of stable co-aggregates. These results establish the critical role of C-terminal, proteolytic fragments of AT3 in the molecular pathomechanism of SCA3, in strong support of the toxic fragment hypothesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
M. Raspe, J. Gillis, H. Krol, S. Krom, K. Bosch, H. van Veen, and E. Reits
Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity
J. Cell Sci., September 15, 2009; 122(18): 3262 - 3271.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
T. Mueller, P. Breuer, I. Schmitt, J. Walter, B. O. Evert, and U. Wullner
CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3
Hum. Mol. Genet., September 1, 2009; 18(17): 3334 - 3343.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Pennuto, I. Palazzolo, and A. Poletti
Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity
Hum. Mol. Genet., April 15, 2009; 18(R1): R40 - R47.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. E. Young, G. A. Garden, R. A. Martinez, F. Tanaka, C. Miguel Sandoval, A. C. Smith, B. L. Sopher, A. Lin, K. H. Fischbeck, L. M. Ellerby, et al.
Polyglutamine-Expanded Androgen Receptor Truncation Fragments Activate a Bax-Dependent Apoptotic Cascade Mediated by DP5/Hrk
J. Neurosci., February 18, 2009; 29(7): 1987 - 1997.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. C. Warby, C. N. Doty, R. K. Graham, J. B. Carroll, Y.-Z. Yang, R. R. Singaraja, C. M. Overall, and M. R. Hayden
Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus
Hum. Mol. Genet., August 1, 2008; 17(15): 2390 - 2404.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Haacke, F. U. Hartl, and P. Breuer
Calpain Inhibition Is Sufficient to Suppress Aggregation of Polyglutamine-expanded Ataxin-3
J. Biol. Chem., June 29, 2007; 282(26): 18851 - 18856.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. O. Evert, J. Araujo, A. M. Vieira-Saecker, R. A. I. de Vos, S. Harendza, T. Klockgether, and U. Wullner
Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation.
J. Neurosci., November 1, 2006; 26(44): 11474 - 11486.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.